Cancer drug development has shifted in recent years as traditional chemotherapies give way to targeted therapies and therapeutic antibodies. Some of the most exciting research in this space is being done by London-based charity Cancer Research UK.

from Forbes – Tech http://ift.tt/1RN6kp9
via IFTTT